Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-761702
Filing Date
2016-11-07
Accepted
2016-11-07 16:25:55
Documents
50
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d191992d10q.htm 10-Q 565303
2 EX-31.1 d191992dex311.htm EX-31.1 5991
3 EX-31.2 d191992dex312.htm EX-31.2 6003
4 EX-32.1 d191992dex321.htm EX-32.1 3799
5 EX-32.2 d191992dex322.htm EX-32.2 3431
  Complete submission text file 0001193125-16-761702.txt   2653650

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kpti-20160930.xml EX-101.INS 429975
7 XBRL TAXONOMY EXTENSION SCHEMA kpti-20160930.xsd EX-101.SCH 30191
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20160930_cal.xml EX-101.CAL 46525
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20160930_def.xml EX-101.DEF 95624
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20160930_lab.xml EX-101.LAB 274251
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20160930_pre.xml EX-101.PRE 182052
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 161978429
SIC: 2834 Pharmaceutical Preparations